Literature DB >> 29351458

Differences in L-type Ca2+ channel activity partially underlie the regional dichotomy in pumping behavior by murine peripheral and visceral lymphatic vessels.

Scott D Zawieja1, Jorge A Castorena-Gonzalez1, Joshua P Scallan2, Michael J Davis1.   

Abstract

We identified a regional dichotomy in murine lymphatic contractile function with regard to vessel location within the periphery or visceral cavity. All vessels isolated from peripheral regions [cervical, popliteal, inguinal, axillary, and internodal inguinal axillary (Ing-Ax)] developed robust contractions with maximal ejection fractions (EFs) of 50-80% in our ex vivo isobaric myograph experiments. Conversely, vessels isolated from the visceral cavity (mesenteric, thoracic duct, and iliac) demonstrated maximal EFs of ≤10%. Using pressure myography, sharp electrode membrane potential recordings, and Ca2+ imaging, we assessed the role of L-type Ca2+ channels in this contractile dichotomy. Ing-Ax membrane potential revealed a ~2-s action potential (AP) cycle (resting -35 mV, spike -5 mV, and plateau -11 mV) with a plateau phase that was significantly lengthened by the L-type Ca2+ channel agonist Bay K8644 (BayK; 100 nM). APs recorded from mesenteric vessels, however, displayed a slower upstroke and an elongated time over threshold. BayK (100 nM) increased the mesenteric AP upstroke velocity and plateau duration but also significantly hyperpolarized the vessel. Contractions of vessels from both regions were preceded by Ca2+ flashes, detected with a smooth muscle-specific endogenous Ca2+ reporter, that typically were coordinated over the length of the vessel. Similar to the membrane potential recordings, Ca2+ flashes in mesenteric vessels were weaker and had a slower rise time but were longer lasting than those in Ing-Ax vessels. BayK (100 nM) significantly increased the Ca2+ transient amplitude and duration in both vessels and decreased time to peak Ca2+ in mesenteric vessels. However, a higher concentration (1 μM) of BayK was required to produce even a modest increase in EF in visceral lymphatics, which remained at <20%. NEW & NOTEWORTHY Lymphatic collecting vessels isolated from murine peripheral tissues, but not from the visceral cavities, display robust contractile behavior similar to lymphatic vessels from other animal models and humans. These differences are partially explained by L-type Ca2+ channel activity as revealed by the first measurements of murine lymphatic action potentials and contraction-associated Ca2+ transients.

Entities:  

Keywords:  lymphatic action potential; lymphatic muscle calcium; lymphatic muscle membrane potential; mouse lymphatic contraction; regional heterogeneity

Mesh:

Substances:

Year:  2018        PMID: 29351458      PMCID: PMC6008139          DOI: 10.1152/ajpheart.00499.2017

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  61 in total

1.  Regional variations of contractile activity in isolated rat lymphatics.

Authors:  Anatoliy A Gashev; Michael J Davis; Michael D Delp; David C Zawieja
Journal:  Microcirculation       Date:  2004-09       Impact factor: 2.628

Review 2.  Dendritic-cell trafficking to lymph nodes through lymphatic vessels.

Authors:  Gwendalyn J Randolph; Veronique Angeli; Melody A Swartz
Journal:  Nat Rev Immunol       Date:  2005-08       Impact factor: 53.106

3.  Myogenic constriction and dilation of isolated lymphatic vessels.

Authors:  Michael J Davis; Ann M Davis; Christine W Ku; Anatoliy A Gashev
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-11-21       Impact factor: 4.733

4.  The effect of transmural pressure on pumping activity in isolated bovine lymphatic vessels.

Authors:  N G McHale; I C Roddie
Journal:  J Physiol       Date:  1976-10       Impact factor: 5.182

5.  Determinants of valve gating in collecting lymphatic vessels from rat mesentery.

Authors:  Michael J Davis; Elaheh Rahbar; Anatoliy A Gashev; David C Zawieja; James E Moore
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-04-01       Impact factor: 4.733

6.  Parathyroid hormone-related protein-(1-34) inhibits intrinsic pump activity of isolated murine lymph vessels.

Authors:  R Mizuno; N Ono; T Ohhashi
Journal:  Am J Physiol Heart Circ Physiol       Date:  2001-07       Impact factor: 4.733

7.  The lymph as a pool of self-antigens.

Authors:  Cristina C Clement; Olaf Rotzschke; Laura Santambrogio
Journal:  Trends Immunol       Date:  2010-12-01       Impact factor: 16.687

8.  Inhibition of the active lymph pump by flow in rat mesenteric lymphatics and thoracic duct.

Authors:  Anatoliy A Gashev; Michael J Davis; David C Zawieja
Journal:  J Physiol       Date:  2002-05-01       Impact factor: 5.182

9.  Platelet-derived growth factor (PDGF)-BB produces NO-mediated relaxation and PDGF receptor β-dependent tonic contraction in murine iliac lymph vessels.

Authors:  Daisuke Maejima; Yoshiko Kawai; Kumiko Ajima; Toshio Ohhashi
Journal:  Microcirculation       Date:  2011-08       Impact factor: 2.628

10.  Contractility patterns of normal and pathologically changed human lymphatics.

Authors:  Waldemar L Olszewski
Journal:  Ann N Y Acad Sci       Date:  2002-12       Impact factor: 5.691

View more
  26 in total

1.  Prolonged intake of desloratadine: mesenteric lymphatic vessel dysfunction and development of obesity/metabolic syndrome.

Authors:  Olga Y Gasheva; Irina Tsoy Nizamutdinova; Laura Hargrove; Cassidy Gobbell; Maria Troyanova-Wood; Sally F Alpini; Sarit Pal; Christina Du; Angie R Hitt; Vlad V Yakovlev; M Karen Newell-Rogers; David C Zawieja; Cynthia J Meininger; Gianfranco D Alpini; Heather Francis; Anatoliy A Gashev
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-11-26       Impact factor: 4.052

2.  Contraction of collecting lymphatics: organization of pressure-dependent rate for multiple lymphangions.

Authors:  C D Bertram; C Macaskill; M J Davis; J E Moore
Journal:  Biomech Model Mechanobiol       Date:  2018-06-08

3.  Silence of the lymphs: some anaesthetic regimens inhibit lymphatic pumping.

Authors:  Katarina J Ruscic; Timothy P Padera
Journal:  J Physiol       Date:  2019-05-12       Impact factor: 5.182

Review 4.  Lymphatic Vessel Network Structure and Physiology.

Authors:  Jerome W Breslin; Ying Yang; Joshua P Scallan; Richard S Sweat; Shaquria P Adderley; Walter L Murfee
Journal:  Compr Physiol       Date:  2018-12-13       Impact factor: 9.090

5.  Evidence of functional ryanodine receptors in rat mesenteric collecting lymphatic vessels.

Authors:  Michiko Jo; Andrea N Trujillo; Ying Yang; Jerome W Breslin
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-07-05       Impact factor: 4.733

6.  Mechanisms of Connexin-Related Lymphedema.

Authors:  Jorge A Castorena-Gonzalez; Scott D Zawieja; Min Li; R Sathish Srinivasan; Alexander M Simon; Cor de Wit; Roger de la Torre; Luis A Martinez-Lemus; Grant W Hennig; Michael J Davis
Journal:  Circ Res       Date:  2018-09-28       Impact factor: 17.367

7.  Simplified method to quantify valve back-leak uncovers severe mesenteric lymphatic valve dysfunction in mice deficient in connexins 43 and 37.

Authors:  Jorge A Castorena-Gonzalez; R Sathish Srinivasan; Philip D King; Alexander M Simon; Michael J Davis
Journal:  J Physiol       Date:  2020-05-10       Impact factor: 5.182

8.  Methods for Assessing the Contractile Function of Mouse Lymphatic Vessels Ex Vivo.

Authors:  Jorge A Castorena-Gonzalez; Joshua P Scallan; Michael J Davis
Journal:  Methods Mol Biol       Date:  2018

9.  Characterization of Mouse Mesenteric Lymphatic Valve Structure and Function.

Authors:  Amélie Sabine; Michael J Davis; Esther Bovay; Tatiana V Petrova
Journal:  Methods Mol Biol       Date:  2018

10.  Kir6.1-dependent KATP channels in lymphatic smooth muscle and vessel dysfunction in mice with Kir6.1 gain-of-function.

Authors:  Michael J Davis; Hae Jin Kim; Scott D Zawieja; Jorge A Castorena-Gonzalez; Peichun Gui; Min Li; Brian T Saunders; Bernd H Zinselmeyer; Gwendalyn J Randolph; Maria S Remedi; Colin G Nichols
Journal:  J Physiol       Date:  2020-05-30       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.